Latest in Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand
Sort by
442 items
-
'We are big dogs': Texans' defense soars off DeMeco Ryans' belief, guidance
As Houston prepares for a divisional-round matchup with Kansas City, its defense is playing at its best.ESPN - 2h -
Havertz's wife shares threats after Arsenal loss
The wife of Arsenal player Kai Havertz has shared abusive messages she received on social media after Arsenal lost to Manchester United in the FA Cup on Sunday.ESPN - 21h -
Los Angeles Is Being Crushed Under the Weight of Inaction
At this point, we’d take concepts of a plan.The New York Times - 1d -
Eli Lilly CEO expects new weight loss pill to be approved next year
Eli Lilly and its rivals are working to develop more convenient options than the injectable Zepbound and Wegovy, which dominate the weight loss drug market.CNBC - 1d -
Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints
Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.MarketWatch - 1d -
Eli Lilly strikes deal for cancer treatment, gives timeline for weight loss pill
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - 1d -
'I feel blessed to get weight-loss jab' - but can the NHS afford it for all?
We meet some of the first NHS patients, as expert says funding everyone eligible would "bankrupt" the service.BBC News - 2d -
'Nothing changes; there is only money': Cut from LIV, former winner shares frustration
Eugenio Chacarra, 24, intends to chase a PGA Tour card once his suspension ends in September.Yahoo Sports - 4d -
Walgreens shares soar 27% on big earnings beat, as drugstore chain cuts costs
Walgreens maintained its fiscal 2025 adjusted earnings guidance, but did not include a sales outlook in its release.CNBC - 4d -
High cost of weight loss drugs drives employers to require nutrition counseling, in boost for startups
Startup Virta Health saw 60% revenue growth last year, topping $100 million, driven by demand for its employer weight loss management program.CNBC - 4d -
Why Elon Musk had to drop his ‘DOGE’ pledge to cut $2 trillion from the federal budget
We told you he would months ago, when he made the promise.MarketWatch - 4d -
'Three-weight champion & retire by 30' - Dubois dreams big
World champion Caroline Dubois plots her journey to superstardom within six years and addresses the publicised family feud with her father and brother.BBC News - 4d -
Bang & Olufsen Confirms Guidance
The consumer-electronics company maintained its full-year guidance and said it is now ready to accelerate its strategic plan to drive profitable growth.The Wall Street Journal - 4d -
Medicare can now cover Eli Lilly's Zepbound for sleep apnea, Health Department agency says
It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other insurance plans for weight loss.CNBC - 5d -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - 5d -
Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly
Zepbound is not covered by Medicare or many other insurance plans as a treatment for weight loss. The injectable treatment costs about $1,000 a month without insurance.MarketWatch - 5d -
Ranking biggest FA Cup upsets this century: Man City shock final defeat, Chelsea loss to Bradford make cut
Wrexham's shocking win over Arsenal doesn't make the cut, taking place eight years before the turn of the centuryCBS Sports - 5d -
Greggs shares drop on sales slowdown
UK bakery chain blames ‘subdued high street footfall’ for weaker earningsFinancial Times - 5d -
Smith dumps Diageo stake over impact of weight-loss drugs on alcohol demand
Veteran stockpicker sells shares in spirits brand because drinks sector is being ‘impacted negatively’Financial Times - 5d -
U.S. Efforts to Cut Emissions Stalled in 2024 as Power Demand Surged
After staying flat for nearly two decades, electricity use is starting to rise again, and the boom in wind and solar power hasn’t kept pace.The New York Times - 5d -
Celebrities share their stories of evacuation and loss amid devastating fires
Actor James Woods broke down in tears, saying 'I'm sorry, I thought I would be stronger than this," as he talked about evacuating. "One day you're swimming in the pool and the next day it's all ...CBS News - 6d -
Shares of California utility Edison International drop 10% as wildfires rage
The decline comes as multiple large fires are burning around Los Angeles, with strong winds making them difficult to contain.CNBC - 6d -
Shares of California utility Edison International drop more than 10% as wildfires rage
Fear and uncertainty surrounding the wildfires in California appear to be weighing on shares of Edison International, whose Southern California Edison is the power utility for the areas directly ...NBC News - 6d -
Eli Lilly's lead in the obesity race has grown. Its recent stock performance says otherwise
Eli Lilly has been one of the worst-performing Club stocks over the past six months.CNBC - 6d -
Louisiana mayor arrested after drug trafficking investigation
Seven people — including Tyrin Truong, mayor of Bogalusa, Louisiana — are facing charges issued in connection with a drug trafficking investigation.CBS News - Jan. 7 -
Ketamine could be reclassified as Class A drug
Illegal use of the drug reached record levels last year, the Home Office said.BBC News - Jan. 7 -
Drug Company to Share Revenues With Indigenous People Who Donated Their Genes
Variant Bio, a small biotech company based in Seattle, is using genetic information from Indigenous people to develop drugs for obesity and diabetes.The New York Times - Jan. 7 -
Next Ups Guidance After Strong Christmas
Next lifted its fiscal-year outlook after Christmas sales were better than expected but said U.K. growth is likely to slow, as higher employer tax costs begin to filter through into the economy.The Wall Street Journal - Jan. 7 -
New FDA guidance aims to improve accuracy of pulse oximeters for people of color
A Food and Drug Administration (FDA) draft guidance would require manufacturers of pulse oximeters to gather far more clinical data to show the devices accurately work across a range of skin ...The Hill - Jan. 6 -
Nvidia, chip stocks pop after Foxconn reports record revenue
Global semiconductor stocks climbed on Monday after Foxconn posted record fourth-quarter revenue, suggesting the AI boom has far more room to run.CNBC - Jan. 6 -
Foxconn Posts Record Fourth-Quarter Revenue on AI Demand
The Taiwan-listed assembler of Apple and Nvidia products posted record revenue for the fourth quarter, helped by robust demand for servers to power burgeoning artificial intelligence technologies.The Wall Street Journal - Jan. 5 -
Eli Health introduces Hormometer to test your hormones on a smartphone
This is how smart your smartphone is getting. Now it will be able to analyze your saliva and do a real-time hormone test.VentureBeat - Jan. 6 -
In France, Drug Traffic Spreads to Small Towns
Even quaint corners of the country are seeing a rise in drug violence and crime. Just ask the mayor of Morlaix, which has a population of about 15,000.The New York Times - Jan. 4 -
Biden finalizes contentious hydrogen guidance
{beacon} Energy & Environment Energy & Environment The Big Story Biden loosens rules for hydrogen credits The Biden administration on Friday finalized fairly strict climate rules for the nascent ...The Hill - Jan. 3 -
Tesla shares slide after it reports first drop in annual deliveries
Tesla's fourth-quarter deliveries report follows a huge late-year rally in the stock that lifted its gain for 2024 to 63%.CNBC - Jan. 3 -
Fee change on investment trusts could badly hit manager revenues
Greencoat UK Wind’s charge shake-up could be copied by other trustsFinancial Times - Jan. 3 -
Boeing Shares Drop After South Korea Plane Crash
A widely used Boeing aircraft, the 737-800, was involved in Sunday’s crash-landing of a Jeju Air flight that killed 179 people.The New York Times - Jan. 3 -
Pharma giant seeks to join lawsuit against FDA over weight loss drugs
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by joining as a defendant, stating it wants to end the "entitlement" some ...The Hill - Jan. 2 -
Scopely scores a billion downloads and $10B in revenue to date
Scopely announced several key milestones achieved to date: $10 billion in lifetime revenue for its mobile games and a billion downloads.VentureBeat - Dec. 30
